Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study

Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer

NCT04914195 ·Status: COMPLETED ·Phase: PHASE3

A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer

NCT00924469 ·Status: COMPLETED ·Phase: PHASE2

Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer

NCT00551044 ·Status: COMPLETED ·Phase: NA

Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448

NCT01132404 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

RecoverPC: Relugolix vs GnRH Agonist in Quality of Life

NCT05765500 ·Status: RECRUITING ·Phase: PHASE2

Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.

NCT02445976 ·Status: COMPLETED ·Phase: PHASE2

Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617

NCT06785636 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies

NCT02854436 ·Status: COMPLETED ·Phase: PHASE2

A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

NCT01834209 ·Status: NO_LONGER_AVAILABLE

Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)

NCT01171898 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

NCT00887198 ·Status: COMPLETED ·Phase: PHASE3

CCI-779 in Treating Patients With Prostate Cancer

NCT00012142 ·Status: COMPLETED ·Phase: PHASE2

Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations

NCT02705846 ·Status: RECRUITING

The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart.

NCT06984159 ·Status: COMPLETED ·Phase: PHASE3

Quinacrine Treatment in Patients With Androgen-Independent Prostate Cancer

NCT00417274 ·Status: COMPLETED ·Phase: PHASE2

Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients

NCT01313273 ·Status: TERMINATED ·Phase: PHASE3

Phase 1 Study of GEN0101 in Patients With Recurrence of CRPC

NCT02502994 ·Status: UNKNOWN ·Phase: PHASE1

Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

NCT01217697 ·Status: APPROVED_FOR_MARKETING

Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients

NCT00630799 ·Status: TERMINATED ·Phase: PHASE3

A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer

NCT01322490 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate

NCT00913263 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Rucaparib in Nonmetastatic prOstAte With BRCAness

NCT03533946 ·Status: TERMINATED ·Phase: PHASE2

A Pilot Study of Lycopene Supplementation in Prostatic Intraepithelial Neoplasia

NCT00178113 ·Status: COMPLETED ·Phase: PHASE1

Atrasentan in Treating Patients With Prostate Cancer

NCT00046943 ·Status: COMPLETED ·Phase: PHASE3

Investigation of Early Hormonotherapy Efficacy of Prostate Cancer

NCT00375687 ·Status: UNKNOWN ·Phase: NA